Latest Healthcare It News

Page 17 of 142
ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.
Ada Torres
Ada Torres
10 Aug 2026
PM Capital Global Opportunities Fund Limited delivered a 41.5% jump in profit after tax to $238 million for FY26 and raised its fully franked dividend guidance to 16 cents for FY27, reflecting strong portfolio returns and robust earnings reserves.
Claire Turing
Claire Turing
10 Aug 2026
Integral Diagnostics (ASX: IDX) posted strong preliminary FY26 results with revenue nearing $790 million and operating EBITDA up 30%, while announcing Jenny Martin as incoming CFO amid leadership transitions.
Ada Torres
Ada Torres
10 Aug 2026
Austco Healthcare is acquiring Medical Communications Systems to deepen its direct sales footprint in South Australia, continuing a string of reseller takeovers that bolster its market presence and earnings.
Ada Torres
Ada Torres
10 Aug 2026
Arena REIT faces a rent payment default from key tenant Edge Early Learning, representing 14% of rental income, prompting default notices and a delay in FY2026 financial results.
Eva Park
Eva Park
10 Aug 2026
Talius has secured a substantial $850,000 purchase order from New Zealand’s Hato Hone St John, adding 8,000 devices and boosting its recurring revenue by $55,000 annually.
Ada Torres
Ada Torres
10 Aug 2026
Flagship Investments Limited reported a sharp 24.1% portfolio decline for the year ended 30 June 2026, underperforming the ASX All Ordinaries Index by 21.7 percentage points. Despite this, the company declared a fully franked final dividend of 5.3 cents per share, supported by retained earnings.
Claire Turing
Claire Turing
7 Aug 2026
Kingfish Limited posted a net loss of NZD 13.6 million for FY2026, underperforming the NZX50 benchmark, but showed early signs of recovery in FY2027. The company re-elected two directors and maintained its focus on quality growth stocks amid a cautious economic outlook.
Victor Sage
Victor Sage
7 Aug 2026
Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.
Ada Torres
Ada Torres
7 Aug 2026
Wellnex Life has agreed to sell its Pain Away brand to Mentholatum Australasia for up to A$21.3 million, aiming to wipe out debt and sharpen its strategic focus.
Ada Torres
Ada Torres
6 Aug 2026
Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.
Victor Sage
Victor Sage
6 Aug 2026
Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.
Ada Torres
Ada Torres
6 Aug 2026

Browse the archive

Full archive